Bulk transcriptomic analyses across five independent cohorts classified CRC subtypes based on LAPTM4B+/LGR5+ stem‐like signatures, linking these subgroups to survival outcomes, transcriptional programs, and genomic profiles. Here, LAPTM4B is linked to colorectal carcinoma.